Short Report

You have full text access to this OnlineOpen article

Biases in human papillomavirus genotype prevalence assessment associatedwith commonly used consensus primers†‡

  1. Paul K. S. Chan1,2,§,*,
  2. Tak-Hong Cheung3,
  3. Ann O. Y. Tam2,
  4. Keith W. K. Lo3,
  5. So-Fan Yim3,
  6. May M. Y. Yu4,
  7. Ka-Fai To4,
  8. Yick-Fu Wong3,
  9. Jo L. K. Cheung2,
  10. Denise P. C. Chan2,
  11. Mamie Hui2,
  12. Margaret Ip2

Article first published online: 19 JUL 2005

DOI: 10.1002/ijc.21299

Issue

International Journal of Cancer

International Journal of Cancer

Volume 118, Issue 1, pages 243–245, 1 January 2006

Additional Information

How to Cite

Chan, P. K. S., Cheung, T.-H., Tam, A. O. Y., Lo, K. W. K., Yim, S.-F., Yu, M. M. Y., To, K.-F., Wong, Y.-F., Cheung, J. L. K., Chan, D. P. C., Hui, M. and Ip, M. (2006), Biases in human papillomavirus genotype prevalence assessment associatedwith commonly used consensus primers. Int. J. Cancer, 118: 243–245. doi: 10.1002/ijc.21299

Author Information

  1. 1

    School of Public Health, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin,New Territories, Hong Kong SAR, China

  2. 2

    Department of Microbiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin,New Territories, Hong Kong SAR, China

  3. 3

    Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Prince of Wales Hospital,Shatin, New Territories, Hong Kong SAR, China

  4. 4

    Department of Anatomical and Cellular Pathology, Faculty of Medicine, The Chinese University of Hong Kong,Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China

  1. §

    Fax: +852-2647-3227

*Department of Microbiology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China

  1. †

    This study was presented in the 22nd International Papillomavirus Conference in Vancouver, 2–6 May 2005.

  2. ‡

    The authors do not have a commercial or other association that might pose a conflict of interest.

Publication History

  1. Issue published online: 26 OCT 2005
  2. Article first published online: 19 JUL 2005
  3. Manuscript Accepted: 18 APR 2005
  4. Manuscript Received: 31 JAN 2005

Funded by

  • Research Grants Council of the Hong Kong Special Administrative Region. Grant Number: CUHK4071/01M

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (64K)

References

  • 1
    Munoz N, Bosch FX, Castellsague X, Diaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJ. Against which human papillomavirus types shall we vaccinate and screen? Int J Cancer 2004; 111: 278–85.
    Direct Link:
  • 2
    Combita AL, Touze A, Bousarghin L, Christensen ND, Coursaget P. Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses. J Virol 2002; 76: 6480–6.
  • 3
    Carter JJ, Koutsky LA, Wipf GC, Christensen ND, Lee SK, Kuypers J, Kiviat N, Galloway DA. The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J Infect Dis 1996; 174: 927–36.
  • 4
    Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, Kiviat N, Galloway DA. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 2000; 181: 1911–9.
  • 5
    Chan PK, Chan DP, To KF, Yu MY, Cheung JL, Cheng AF. Evaluation of extraction methods from paraffin wax embedded tissues for PCR amplification of human and viral DNA. J Clin Pathol 2001; 54: 401–3.
  • 6
    de Roda Husman AM, Walbommers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995; 76: 1057–62.
  • 7
    Ting Y, Manos MM. Detection and typing of genital human papillomavirus. In: InnisMA, GelfondDH, SninskyJJ, WhiteTJ. PCR protocol: a guide to methods and applications. San Diego: Academic Press, 1990. 356–67.
  • 8
    Chan PK, Li WH, Chan MY, Ma WL, Cheung JL, Cheng AF. High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions. J Med Virol 1999; 59: 232–8.
    Direct Link:
  • 9
    Coutlee F, Gravitt P, Kornegay J, Hankins C, Richardson H, Lapointe N, Voyer H, Franco E. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol 2002; 40: 902–7.
  • 10
    Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003; 88: 63–73.
  • 11
    Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38: 357–61.
  • 12
    Clifford GM, Smith JS, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003; 89: 101–5.
  • 13
    Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, Klein RS, Burk RD. PCR detection of human papillomavirus: comparison between MY09/11 and GP5+/6+ primer system. J Clin Microbiol 1997; 35: 1304–10.
  • 14
    Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ, International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518–27.
  • 15
    De Vuyst H, Steyaert S, Van Renterghem L, Claeys P, Muchiri L, Sitati S, Vansteelandt S, Quint W, Kleter B, Van Marck E, Temmerman M. Distribution of human papillomavirus in a family planning population in Nairobi, Kenya. Sex Transm Dis 2003; 30: 137–42.
View Full Article (HTML) Get PDF (64K)